AngioGenex News Releases + Media Coverage

AngioGenex, Inc. (Ticker: AGGX) announced an exclusive agreement with Memorial Sloan Kettering Cancer Center (MSK) to license and advance a series of anti-ID compounds through the regulatory process and into human clinical…

AngioGenex, Inc. (Ticker: AGGX) announced today that Mr. Michael Aronstein, veteran financier and the President/Chief Investment Officer and Portfolio Manager of Marketfield Asset Management, LLC, has agreed to assume the…